Analyst Price Target is $23.75
▲ +11.82% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Option Care Health in the last 3 months. The average price target is $23.75, with a high forecast of $25.00 and a low forecast of $21.00. The average price target represents a 11.82% upside from the last price of $21.24.
Current Consensus is
The current consensus among 5 investment analysts is to buy stock in Option Care Health. This Buy consensus rating has held steady for over two years.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.